Opioid addiction is “a chronic brain disorder that requires long-term treatment,” and CBD must be part of the solution, says Dr. Yasmin Hurd, a renowned professor of Neuroscience, Psychiatry, and Pharmacology at Mount Sinai School of Medicine whose work has been cited more than 5,000 times.
“CBD reduces the reward-seeking effect that morphine has on individuals with opioid-use disorder,” Dr. Hurd said in an editorial published in the American Journal of Psychiatry.
Cravings and anxiety are reduced in individuals who take cannabis while trying to kick heroin use, according Dr. Hurd, who also heads the Mount Sinai Addictions Institute in New York.
“Intriguingly … cannabidiol resulted in a maintained reduction in heroin craving even a week after the last administration,” said Professor Hurd.
“This finding may be of particular benefit in treating opioid-use disorder, because the protective effects in reducing craving, and thus risk of relapse, could be maintained even if the individual has missed a daily dose.”
A full battery of research must be explored to determine the potential of cannabidiol for opioid-use-disorder treatment, she said.
She said that opioid-related deaths, opioid prescriptions and opioid-related motor vehicle fatalities were reduced in states with medical marijuana laws.
“Molecular genetics and new medication strategies for opioid addiction” was published in the American Journal of Psychiatry, August 2018.
Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to CannabisFindings.com with appropriate and specific direction to the original content.